SHR-5428

N/A

Report date: 2023/08/25 16:57:11
NME

Base Information

Drug NameSHR-5428
Drug Alias NameSHR5428SHR-5428
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 7 inhibitors
TargetsCyclin-dependent kinase 7
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Hengrui Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Hengrui Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A